Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
Iglseder S, Iglseder A, Beliveau V, Heugenhauser J, Gizewski ER, Kerschbaumer J, Stockhammer G, Uprimny C, Virgolini I, Dudas J, Nevinny-Stickel M, Nowosielski M, Scherfler C. Iglseder S, et al. Among authors: virgolini i. J Neurooncol. 2023 Sep;164(3):711-720. doi: 10.1007/s11060-023-04414-3. Epub 2023 Sep 14. J Neurooncol. 2023. PMID: 37707754 Free PMC article.
Investigating patient eligibility for anti-amyloid monoclonal antibody treatment of Alzheimer's disease: real-world data from an Austrian psychiatric memory clinic population.
Defrancesco M, Gizewski ER, Mangesius S, Galijasevic M, Virgolini I, Kroiss A, Marksteiner J, Jehle J, Doganyigit B, Hofer A. Defrancesco M, et al. Among authors: virgolini i. BJPsych Open. 2024 Sep 23;10(5):e160. doi: 10.1192/bjo.2024.747. BJPsych Open. 2024. PMID: 39308280 Free PMC article.
Real-world Outcomes and Predictive Biomarkers for 177Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study.
Kafka M, Horninger A, di Santo G, Virgolini I, Neuwirt H, Unterrainer LM, Kunte SC, Deiss E, Paffenholz P, Heidenreich A, Rasul S, Einspieler H, Shariat SF, Rajwa P, Dozauer R, Tsaur I, Medlock E, Rölz N, Rausch S, la Fougère C, Trautwein N, Roesch MC, Merseburger AS, Zattoni F, Sepulcri M, Ladurner M, Bektic J, Gandaglia G, Horninger W, Heidegger I. Kafka M, et al. Among authors: virgolini i. Eur Urol Oncol. 2024 Jun;7(3):421-429. doi: 10.1016/j.euo.2023.07.018. Epub 2023 Aug 19. Eur Urol Oncol. 2024. PMID: 37604763 Free article.
Comparison of 99mTc radiolabeled somatostatin antagonist with [68 Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor.
Opalinska M, Lezaic L, Decristoforo C, Kolenc P, Mikolajczak R, Studen A, Simoncic U, Virgolini I, Trofimiuk-Muldner M, Garnuszek P, Rangger C, Fani M, Glowa B, Skorkiewicz K, Hubalewska-Dydejczyk A. Opalinska M, et al. Among authors: virgolini i. Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4110-4111. doi: 10.1007/s00259-023-06335-9. Epub 2023 Jul 15. Eur J Nucl Med Mol Imaging. 2023. PMID: 37452871 Free PMC article. No abstract available.
Imaging Fibrosis.
Sviridenko A, di Santo G, Virgolini I. Sviridenko A, et al. Among authors: virgolini i. PET Clin. 2023 Jul;18(3):381-388. doi: 10.1016/j.cpet.2023.02.004. Epub 2023 Mar 27. PET Clin. 2023. PMID: 36990946 Review.
Efficacy and safety of rechallenge with [177Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer.
Santo G, Di Santo G, Sviridenko A, Bayerschmidt S, Wirth L, Scherbauer F, Lehmann P, von Guggenberg E, Decristoforo C, Heidegger-Pircher I, Bektic J, Virgolini I. Santo G, et al. Among authors: virgolini i. Eur J Nucl Med Mol Imaging. 2024 Sep 3. doi: 10.1007/s00259-024-06905-5. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 39225826
317 results